go back

Rhode Island rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $398,107 · 10th–90th $398,107–$416,8690%50%90th$398,107Professionalmedian $407,380 · 10th–90th $407,380–$407,3800%50%100%$407,380

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$398,107.17 / $398,107.17 / $416,869.38
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$407,380.28 / $407,380.28 / $407,380.28